New Notices
- New Notice of Intent to Revise: Changes to General Notices, Section 1 (posted 28-Feb-2024)
- New Notice of Intent to Revise: Cetyl Palmitate (posted 23-Feb-2024)
- New Notice of Intent to Revise: Dapsone Tablets (posted 23-Feb-2024)
- New Notice of Intent to Revise: Methylprednisolone Injectable Suspension (posted 23-Feb-2024)
- New Notice of Intent to Revise: Polyethylene Glycol (posted 23-Feb-2024)
- New Notice of Intent to Revise: Roflumilast (posted 23-Feb-2024)
- New Notice of Intent to Revise: Sucrose (posted 23-Feb-2024)
- New General Chapter Prospectus: <1785> Osmolality/Osmolarity- Practical Considerations (posted 23-Feb-2024; input deadline 24-Mar-2024)
- New Publication Announcement: Chemical Information Updates (posted 12-Feb-2024)
- New Publication Announcement: Monographs Affected by Revision to <541> Titrimetry (posted 12-Feb-2024)
- New Publication Announcement: Update on the Extended Implementation Date for the Omission of Monographs for Carbomer 934, Carbomer 934P, Carbomer 940, Carbomer 941, and Carbomer 1342 (posted 01-Feb-2024)
- New Pending Revision Notice: Carbamazepine Extended-Release Tablets (posted 26-Jan-2024)
- New Pending Revision Notice: Chlorpromazine Hydrochloride Tablets (posted 26-Jan-2024)
- New Pending Revision Notice: Rivaroxaban Tablets (posted 26-Jan-2024)
- New Pending Revision Notice: Torsemide Tablets (posted 26-Jan-2024)
- New General Chapter Prospectus: <470> Determination of Diethylene Glycol and Ethylene Glycol in Polyethylene Glycol (posted 26-Jan-2024; input deadline 29-Feb-2024)
- New Notice of Intent to Revise: Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets (posted 29-Dec-2023)
- New Notice of Intent to Revise: Gadopentetate Dimeglumine Injection (posted 29-Dec-2023)
- New General Chapter Prospectus: <315> NMR Number-average Molecular Weight Determination for LG Polymers (posted 29-Dec-2023; input deadline 28-Jan-2024)
- New General Chapter Prospectus: <316> GPC Molecular Weight and Polydispersity Determination for LG Polymers Using Universal Calibration (posted 29-Dec-2023; input deadline 28-Jan-2024)
- New General Announcement: Comment Period Extended for 〈823〉 Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses and 〈1823〉 Positron Emission Tomography Drugs—Information Appearing in Pharmacopeial Forum 49(5) (posted 17-Nov-2023)
- New Pending Revision Notice: Lithium Oral Solution (posted 17-Nov-2023)
- New Pending Revision Notice: Rifabutin Capsules (posted 17-Nov-2023)
- New General Chapter Prospectus: <317> ICP OES Testing for Sodium Hydroxide and Potassium Hydroxide (posted 17-Nov-2023; input deadline 16-Dec-2023)
- New General Announcement: New Chapter <477> User-Determined Reporting Thresholds and its Implementation in USP-NF Monographs (posted 01-Nov-2023)